Considering tumor-infiltrating FOXP3+ Treg cells may promote the immune escape of cancer cells, our findings suggest that USP11 could serve as a potential therapeutic target for the treatment of tumors with FOXP3-induced immune evasion. This evidence concerns the gene FOXP3 and cancer.